SFM
ACOR

Systematic Financial Management’s Acorda Therapeutics ACOR Stock Holding History

Systematic Financial Management’s Portfolio ACOR Stock Details ACOR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-761
Closed -$1.21M – 676
2019
Q1 		$1.21M Buy
761
+202
+36% +$364K 0.04% 396
2018
Q4 		$1.04M Buy
559
+177
+46% +$385K 0.03% 466
2018
Q3 		$901K Sell
382
-1
-0.3% -$3.1K 0.02% 576
2018
Q2 		$1.32M Buy
+383
New +$1.17M 0.03% 467

Other funds holding ACOR

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
SCM
Scopia Capital Management New York $146M AUM 25.93% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

Systematic Financial Management's ACOR Position: Q2 2019 in Review

Systematic Financial Management sold out of Acorda Therapeutics (ACOR) in Q2 2019, closing a stake of 761 shares — an estimated $1.21M sold.

Systematic Financial Management first reported a position in ACOR in Q2 2018 and held it in 4 quarters. The position peaked at $1.32M in Q2 2018. 163 funds tracked by Wall St. Rank hold ACOR as of Q2 2019.

  • Systematic Financial Management reported no remaining Acorda Therapeutics position as of Q2 2019 after selling out during the quarter.
  • Systematic Financial Management sold 761 Acorda Therapeutics shares in Q2 2019, an estimated $1.21M.
  • Systematic Financial Management first reported a position in Acorda Therapeutics in Q2 2018 and held it in 4 quarters.
  • Systematic Financial Management's Acorda Therapeutics position peaked at $1.32M in Q2 2018.
  • 163 funds tracked by Wall St. Rank held Acorda Therapeutics as of Q2 2019.

Based on Systematic Financial Management's 13F filing for Q2 2019, filed 26 Jul 2019.